Blog – Page 13 – Eloquest Healthcare, Inc.

Jan92019

Evidence-Based Decision Making for the Prevention of Catheter-Related Bloodstream Infections and Medical Adhesive-Related Skin Injuries

CLABSI, Detachol Adhesive Remover, Healthcare Education, Infection Prevention, MARSIBy Eloquest Marketing January 9, 2019

While catheters provide numerous benefits to their users, there can be a health burden associated with their use, as they may promote catheter-related bloodstream infection (CRBSI*) and medical adhesive-related skin injuries (MARSIs). A publication reviewing the qualitative and quantitative evidence supporting the use of Detachol® Liquid Adhesive for the reduction of CRBSI and MARSI can…

Details

Dec192018

2018: A Year In Review

Healthcare Education, Infection PreventionBy Jennifer Batsios December 19, 2018

As 2018 comes to a close, we would like to thank you for being part of the Eloquest Healthcare Blog! We hope you have found our posts both informative and impactful to your professional career. As the new year kicked off, we welcomed our first guest blogger, Jo Ann Brooks PhD, RN, FAAN, FCCP, former…

Details

Dec52018

Living With An Insulin Pump

CLABSI, Healthcare Education, Infection PreventionBy Eloquest Marketing December 5, 2018

Of the 200 million people worldwide who have been diagnosed with diabetes, millions receive their diabetes care through insulin pump therapy and use continuous glucose monitors (CGMs) and insulin pumps.[1] This may result in improved diabetes care and greater control over users’ blood glucose levels. “My overall health is better. Insulin delivery is better, so…

Details

Nov202018

Living with a Vascular Access Device

CLABSI, Healthcare Education, Infection Prevention, Vascular AccessBy Eloquest Marketing November 20, 2018

Vascular Access Devices (VADs) are more prevalent than ever, with some reports estimating that at any point in time there may be 5 million patients living with a VAD.[1] These patients may either be in the hospital receiving care or at home receiving longterm care, and while VADs offer flexibility to patients, VADs still have…

Details

Oct262018

Engaging Your Team Through Community Service

Eloquest HealthcareBy Jennifer Batsios October 26, 2018

Employee engagement plays a critical role in the success of any company, no matter what size or industry. As we enter the last quarter of the year, now is the perfect time to increase staff engagement by offering a way for them to give back to the community. Employee giving programs address many factors that…

Details

Oct32018

Mastisol® Liquid Adhesive: Evidence‐Based Decision Making for the Prevention of Catheter‐Related Blood Stream Infections

CLABSI, Healthcare Education, Infection Prevention, Mastisol Liquid Adhesive, Vascular AccessBy Eloquest Marketing October 3, 2018

The public health burden associated with catheter‐related bloodstream infection (CRBSI*) is substantial. A publication reviewing the qualitative and quantitative evidence supporting the use of Mastisol® Liquid Adhesive for the reduction of CRBSI can be downloaded here. In this blog, we’ll review the important findings detailed in this publication. CRBSI vs CLABSI These two…

Details

Sep52018

Addressing the Dressing: Improving Vascular Access Dressing Disruption

CLABSI, Healthcare Education, Infection Prevention, Mastisol Liquid Adhesive, Vascular AccessBy Eloquest Marketing September 5, 2018

The US Centers for Disease Control and Prevention (CDC) and The Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing integrity is a critical factor for the prevention of hospital acquired infection. Michelle DeVries, BS, MPH, CIC, VA-BC, Senior Infection Control Officer at Methodist Hospitals, Indiana, reviews current practice guidelines, the emerging literature, and her…

Details

Jul112018

Financial Impact of Surgical Site Infections (SSIs)

Healthcare Education, Infection Prevention, SSIBy Eloquest Marketing July 11, 2018

Welcome to a new 3-part series focusing on SSIs. SSIs are the most common type of hospital-acquired infection (HAI). They occur an estimated 160,000 to 300,000 times per year and account for more than 20% of all HAIs.1 And while the negative clinical outcomes associated with SSIs (ie, morbidity and mortality) are commonly known, there…

Details

May232018

LVADs: Minimizing Driveline Infections at Home

Detachol Adhesive Remover, Healthcare Education, Infection Prevention, Mastisol Liquid AdhesiveBy Eloquest Marketing May 23, 2018

The previous blog of this 2‐part series focused on Left Ventricular Assist Devices (LVADs), including the prevalence of use, the types of patients treated, and the associated risks of LVAD‐associated infections. (View Blog 1 of 2) Part 2 of the series will focus on minimizing driveline infections once the patient goes home. LVADs have revolutionized…

Details

May22018

CHF, LVADs, and Reducing Infection Risk

Detachol Adhesive Remover, Healthcare Education, Infection Prevention, Mastisol Liquid AdhesiveBy Eloquest Marketing May 2, 2018

Welcome to the first of a 2-part series on Left Ventricular Assist Devices (LVADs). Part 1 will provide an overview of LVADs, types of patients treated and the associated risks. Congestive Heart Failure (CHF) is a leading cause of death worldwide. CHF is estimated to impact over 20 million people in the world, 2.2 million…

Details